search
Back to results

AIR (Artificial Implant for Medial Meniscus Replacement) Study (AIR)

Primary Purpose

Meniscectomy, Osteo Arthritis Knee

Status
Terminated
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Trammpolin® meniscus prosthesis
Sponsored by
ATRO Medical B.V.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Meniscectomy

Eligibility Criteria

30 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Has medial compartment joint pain with > 6 months ago a medial partial meniscectomy as confirmed by patient history and MRI
  2. Has a KOOS Pain of ≤ 75 (100 being no pain and the highest attainable score)
  3. Is between age 30 and 65 years (inclusive) at the time of screening
  4. Has neutral alignment ± 5° of the mechanical axis, i.e., the angle formed by a line drawn from the center of the femoral head to the medial tibial spine and a line drawn from the medial tibial spine to the center of the ankle joint, as confirmed by X-ray
  5. Is willing to be implanted with the Trammpolin® meniscus prosthesis.
  6. Is able to do the study required follow up visits, questionnaires, X-rays, CT-scans, and MRI's
  7. Is able and willing to understand and sign the study Informed Consent Form
  8. Is able to read and understand the national language of the country in which the relevant clinical site is located

Exclusion Criteria:

  1. Has a symptomatic knee because of a tear that could be addressed by a repeat partial meniscectomy
  2. Has evidence of a modified Outerbridge Grade IV cartilage loss on the medial tibial plateau or femoral condyle that potentially could contact a Trammpolin® meniscus prosthesis (e.g., a focal lesion > 0.5 cm2 correlating to a circular defect of > 8 mm in diameter)
  3. Has lateral compartment pain and Grade III or Grade IV modified Outerbridge cartilage score in the lateral compartment
  4. Has a varus or valgus knee deformity of > 5° requiring a tibial or femoral osteotomy
  5. Has a varus alignment that is not passively correctable
  6. Has a laxity level of more than Grade II (IKDC), primary or secondary to an injury of the anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or lateral collateral ligament (LCL) and/or medial collateral ligament (MCL)
  7. Has significant trochlear dysplasia, patellar instability or symptomatic patellar misalignment
  8. Has patellar compartment pain and Grade III or Grade IV modified Outerbridge cartilage score in the patellar compartment.
  9. Compared to a normal knee, has obvious radiological evidence of medial femoral squaring, anatomical variance in the medial tibial plateau, or irregularly shaped cartilage surface
  10. Had an ACL reconstruction performed < 9 months prior to surgery
  11. Has a BMI > 32.5 at the time of screening
  12. Received any type of prosthetic knee implant made of artificial non-resorbable plastic, metal or ceramic, not including the Trammpolin® meniscus prosthesis
  13. Has a knee flexion contracture > 10°
  14. Has flexion < 90°
  15. Had a previous medial femoral condyle surgery (not including microfracture) or High Tibial Osteotomy (HTO)
  16. Has insufficiency fractures or avascular necrosis of the medial compartment
  17. Has an active infection or tumor (local or systemic)
  18. Has any type of knee joint inflammatory disease including Sjogren's syndrome
  19. Has neuropathic knee osteoarthropathy, also known as Charcot joint
  20. Has any medical condition that does not allow possible arthroscopy of the knee
  21. Has neurological deficit (sensory, motor, or reflex)
  22. Is currently involved in another investigation of the lower extremity
  23. Anticipates having another lower extremity surgery during the study period
  24. Is contraindicated for corticosteroid injections (i.e., patients with allergy to any of the components or with idiopathic thrombocytopenic purpura)
  25. Has received any corticosteroid knee injections ≤ 3 months prior to surgery
  26. Has chondrocalcinosis
  27. Has proven osteoporosis
  28. Is on immunostimulating or immunosuppressing agents
  29. Has ipsilateral or contralateral lower limb joint conditions that may affect ambulation or KOOS (e.g. have a leg length discrepancy > 2.5 cm [1 inch], causing a noticeable limp)
  30. Is a female who is lactating, expecting, or is intending to become pregnant during the study period
  31. Is an active smoker
  32. Is mentally incapacitated (incapable of appraising or controlling conduct) or have mental disability (e.g., dementia or Alzheimer's)
  33. Is a prisoner
  34. Has a condition or be in a situation that, in the Investigator's opinion, may confound the study results, or may interfere significantly with the subject's participation in the study

Sites / Locations

  • Maastricht UMC+
  • Radboud UMC
  • Sint Maartenskliniek

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Trammpolin® meniscus prosthesis

Arm Description

The patients will be implanted with the Trammpolin® meniscus prosthesis

Outcomes

Primary Outcome Measures

Knee injury and Osteoarthritis Outcome Score (KOOS) Pain sub-scale
Performance of the Trammpolin® meniscus prosthesis in improving pain
Trammpolin® meniscus prosthesis device related complications
The nature and frequency of all adverse events observed during the study

Secondary Outcome Measures

KOOS Pain sub-scale
KOOS Pain sub-scale
Overall KOOS scale
Overall KOOS scale
Lysholm scale
Lysholm scale
IKDC objective scale
IKDC objective scale
Knee X-ray
Joint space measurement
Knee MRI
Cartilage damage and extrusion

Full Information

First Posted
October 3, 2018
Last Updated
August 24, 2021
Sponsor
ATRO Medical B.V.
search

1. Study Identification

Unique Protocol Identification Number
NCT03696836
Brief Title
AIR (Artificial Implant for Medial Meniscus Replacement) Study
Acronym
AIR
Official Title
Treatment of Medial Knee Joint Pain With the Trammpolin® Meniscus Prosthesis
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Terminated
Why Stopped
Halted prematurely
Study Start Date
October 11, 2018 (Actual)
Primary Completion Date
January 7, 2021 (Actual)
Study Completion Date
July 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ATRO Medical B.V.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The AIR Study is a multi-center, prospective, interventional clinical trial with the objective to evaluate the safety and performance of the Trammpolin® meniscus prosthesis system.
Detailed Description
The Trammpolin® meniscus prosthesis is intended to replace the native medial meniscus to provide pain relief in the medial compartment of the knee joint, when this is caused by medial partial meniscectomy. Patients who meet the inclusion/exclusion criteria and who are implanted with the Trammpolin® meniscus prosthesis will be followed for 2 years. The patient reported outcome measures for knee pain and function, and knee clinical condition by MRI and X-ray is assessed post-operative compared to pre-operative.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Meniscectomy, Osteo Arthritis Knee

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
5 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Trammpolin® meniscus prosthesis
Arm Type
Experimental
Arm Description
The patients will be implanted with the Trammpolin® meniscus prosthesis
Intervention Type
Device
Intervention Name(s)
Trammpolin® meniscus prosthesis
Intervention Description
Trammpolin® meniscus prosthesis is an anatomically shaped, synthetic medial meniscus replacement
Primary Outcome Measure Information:
Title
Knee injury and Osteoarthritis Outcome Score (KOOS) Pain sub-scale
Description
Performance of the Trammpolin® meniscus prosthesis in improving pain
Time Frame
24 Months
Title
Trammpolin® meniscus prosthesis device related complications
Description
The nature and frequency of all adverse events observed during the study
Time Frame
24 Months
Secondary Outcome Measure Information:
Title
KOOS Pain sub-scale
Description
KOOS Pain sub-scale
Time Frame
6 Weeks; 3, 6 and 12 Months
Title
Overall KOOS scale
Description
Overall KOOS scale
Time Frame
6 Weeks; 3, 6, 12 and 24 Months
Title
Lysholm scale
Description
Lysholm scale
Time Frame
6 Weeks; 3, 6, 12 and 24 Months
Title
IKDC objective scale
Description
IKDC objective scale
Time Frame
6 Weeks; 3, 6, 12 and 24 Months
Title
Knee X-ray
Description
Joint space measurement
Time Frame
6 Weeks; 12 and 24 Months
Title
Knee MRI
Description
Cartilage damage and extrusion
Time Frame
12 and 24 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Has medial compartment joint pain with > 6 months ago a medial partial meniscectomy as confirmed by patient history and MRI Has a KOOS Pain of ≤ 75 (100 being no pain and the highest attainable score) Is between age 30 and 65 years (inclusive) at the time of screening Has neutral alignment ± 5° of the mechanical axis, i.e., the angle formed by a line drawn from the center of the femoral head to the medial tibial spine and a line drawn from the medial tibial spine to the center of the ankle joint, as confirmed by X-ray Is willing to be implanted with the Trammpolin® meniscus prosthesis. Is able to do the study required follow up visits, questionnaires, X-rays, CT-scans, and MRI's Is able and willing to understand and sign the study Informed Consent Form Is able to read and understand the national language of the country in which the relevant clinical site is located Exclusion Criteria: Has a symptomatic knee because of a tear that could be addressed by a repeat partial meniscectomy Has evidence of a modified Outerbridge Grade IV cartilage loss on the medial tibial plateau or femoral condyle that potentially could contact a Trammpolin® meniscus prosthesis (e.g., a focal lesion > 0.5 cm2 correlating to a circular defect of > 8 mm in diameter) Has lateral compartment pain and Grade III or Grade IV modified Outerbridge cartilage score in the lateral compartment Has a varus or valgus knee deformity of > 5° requiring a tibial or femoral osteotomy Has a varus alignment that is not passively correctable Has a laxity level of more than Grade II (IKDC), primary or secondary to an injury of the anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or lateral collateral ligament (LCL) and/or medial collateral ligament (MCL) Has significant trochlear dysplasia, patellar instability or symptomatic patellar misalignment Has patellar compartment pain and Grade III or Grade IV modified Outerbridge cartilage score in the patellar compartment. Compared to a normal knee, has obvious radiological evidence of medial femoral squaring, anatomical variance in the medial tibial plateau, or irregularly shaped cartilage surface Had an ACL reconstruction performed < 9 months prior to surgery Has a BMI > 32.5 at the time of screening Received any type of prosthetic knee implant made of artificial non-resorbable plastic, metal or ceramic, not including the Trammpolin® meniscus prosthesis Has a knee flexion contracture > 10° Has flexion < 90° Had a previous medial femoral condyle surgery (not including microfracture) or High Tibial Osteotomy (HTO) Has insufficiency fractures or avascular necrosis of the medial compartment Has an active infection or tumor (local or systemic) Has any type of knee joint inflammatory disease including Sjogren's syndrome Has neuropathic knee osteoarthropathy, also known as Charcot joint Has any medical condition that does not allow possible arthroscopy of the knee Has neurological deficit (sensory, motor, or reflex) Is currently involved in another investigation of the lower extremity Anticipates having another lower extremity surgery during the study period Is contraindicated for corticosteroid injections (i.e., patients with allergy to any of the components or with idiopathic thrombocytopenic purpura) Has received any corticosteroid knee injections ≤ 3 months prior to surgery Has chondrocalcinosis Has proven osteoporosis Is on immunostimulating or immunosuppressing agents Has ipsilateral or contralateral lower limb joint conditions that may affect ambulation or KOOS (e.g. have a leg length discrepancy > 2.5 cm [1 inch], causing a noticeable limp) Is a female who is lactating, expecting, or is intending to become pregnant during the study period Is an active smoker Is mentally incapacitated (incapable of appraising or controlling conduct) or have mental disability (e.g., dementia or Alzheimer's) Is a prisoner Has a condition or be in a situation that, in the Investigator's opinion, may confound the study results, or may interfere significantly with the subject's participation in the study
Facility Information:
Facility Name
Maastricht UMC+
City
Maastricht
ZIP/Postal Code
6229 HX
Country
Netherlands
Facility Name
Radboud UMC
City
Nijmegen
ZIP/Postal Code
6525 GA
Country
Netherlands
Facility Name
Sint Maartenskliniek
City
Ubbergen
ZIP/Postal Code
6574 NA
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

AIR (Artificial Implant for Medial Meniscus Replacement) Study

We'll reach out to this number within 24 hrs